Gene-drug interactions (data source: DGIdb)
Gene Name Entrez ID Drug Name Chembl ID Interaction Types Sources publications
CDK2 1017 BMS-387032 CHEMBL296468 inhibitor TdgClinicalTrial, GuideToPharmacologyInteractions, ChemblInteractions, CancerCommons, TTD
CDK2 1017 INDIRUBIN SULFATE CHEMBL258805 inhibitor GuideToPharmacologyInteractions, ChemblInteractions, DrugBank 11752352, 17139284, 17016423, 10592235
CDK2 1017 MILCICLIB CHEMBL564829 inhibitor GuideToPharmacologyInteractions, ChemblInteractions
CDK2 1017 DINACICLIB CHEMBL2103840 inhibitor MyCancerGenome, ClearityFoundationClinicalTrial, GuideToPharmacologyInteractions, ChemblInteractions, CancerCommons, MyCancerGenomeClinicalTrial, TTD
CDK2 1017 ALOISINE A CHEMBL75680 inhibitor GuideToPharmacologyInteractions
CDK2 1017 AZD-5438 CHEMBL488436 inhibitor GuideToPharmacologyInteractions, ChemblInteractions
CDK2 1017 CHEMBL261720 CHEMBL261720 inhibitor GuideToPharmacologyInteractions
CDK2 1017 PENTOBARBITAL CHEMBL448 inhibitor GuideToPharmacologyInteractions
CDK2 1017 CHEMBL1082552 CHEMBL1082552 inhibitor DrugBank 11752352, 10592235
CDK2 1017 CHEMBL48109 CHEMBL48109 DrugBank 17139284, 17016423, 10592235
CDK2 1017 HYMENIALDISINE CHEMBL361708 inhibitor DrugBank 11752352, 17139284, 17016423, 10592235
CDK2 1017 CHEMBL127907 CHEMBL127907 DrugBank 17139284, 17016423, 10592235
CDK2 1017 CHEMBL47590 CHEMBL47590 DrugBank 17139284, 17016423, 10592235
CDK2 1017 OLOMOUCINE II CHEMBL1094304 DrugBank 10592235
CDK2 1017 ADENOSINE DIPHOSPHATE CHEMBL14830 DrugBank 10592235
CDK2 1017 CHEMBL115220 CHEMBL115220 DrugBank 10592235
CDK2 1017 CHEMBL359020 CHEMBL359020 DrugBank 10592235
CDK2 1017 CHEMBL400520 CHEMBL400520 DrugBank 10592235
CDK2 1017 CHEMBL319467 CHEMBL319467 DrugBank 10592235
CDK2 1017 CHEMBL258040 CHEMBL258040 DrugBank 10592235
CDK2 1017 CHEMBL231950 CHEMBL231950 DrugBank 10592235
CDK2 1017 CHEMBL46817 CHEMBL46817 DrugBank 10592235
CDK2 1017 CHEMBL278894 CHEMBL278894 DrugBank 10592235
CDK2 1017 CHEMBL478409 CHEMBL478409 DrugBank 10592235
CDK2 1017 CHEMBL1234087 CHEMBL1234087 DrugBank 10592235
CDK2 1017 CHEMBL1234089 CHEMBL1234089 DrugBank 10592235
CDK2 1017 CHEMBL457047 CHEMBL457047 DrugBank 10592235
CDK2 1017 CHEMBL487738 CHEMBL487738 DrugBank 10592235
CDK2 1017 CHEMBL463580 CHEMBL463580 DrugBank 10592235
CDK2 1017 CHEMBL340813 CHEMBL340813 DrugBank 10592235
CDK2 1017 CHEMBL482193 CHEMBL482193 DrugBank 10592235
CDK2 1017 CHEMBL303958 CHEMBL303958 DrugBank 10592235
CDK2 1017 CHEMBL1098060 CHEMBL1098060 DrugBank 10592235
CDK2 1017 CHEMBL101801 CHEMBL101801 DrugBank 10592235
CDK2 1017 RALTITREXED CHEMBL225071 NCI 10047461
CDK2 1017 DEXAMETHASONE CHEMBL384467 NCI 10867026
CDK2 1017 ENMD-981693 CHEMBL52885 inhibitor TTD
CDK2 1017 (7S)-HYDROXYL-STAUROSPORINE CHEMBL574737 inhibitor ChemblInteractions
CDK2 1017 CHEMBL1802728 CHEMBL1802728 inhibitor GuideToPharmacologyInteractions
CDK2 1017 CHEMBL524266 CHEMBL524266 inhibitor GuideToPharmacologyInteractions
CDK2 1017 PURVALANOLA CHEMBL23327 inhibitor GuideToPharmacologyInteractions
CDK2 1017 PURVALANOL B CHEMBL23254 inhibitor GuideToPharmacologyInteractions
CDK2 1017 SELICICLIB CHEMBL14762 inhibitor MyCancerGenome, TdgClinicalTrial, GuideToPharmacologyInteractions, ChemblInteractions, TTD
CDK2 1017 STAUROSPORINE CHEMBL388978 NCI, DrugBank 17139284, 17016423, 7629160
CDK2 1017 CHEMBL47302 CHEMBL47302 DrugBank 17139284, 17016423, 10592235
CDK2 1017 CHEMBL191632 CHEMBL191632 DrugBank 17139284, 17016423
CDK2 1017 CHEMBL269881 CHEMBL269881 DrugBank 17139284, 17016423, 10592235
CDK2 1017 CHEMBL99842 CHEMBL99842 DrugBank 17139284, 17016423, 10592235
CDK2 1017 CHEMBL1234009 CHEMBL1234009 DrugBank 17139284, 17016423, 10592235
CDK2 1017 CHEMBL354634 CHEMBL354634 DrugBank 17139284, 17016423, 10592235
CDK2 1017 CHEMBL141247 CHEMBL141247 DrugBank 17139284, 17016423, 10592235
CDK2 1017 CHEMBL150261 CHEMBL150261 DrugBank 17139284, 17016423, 10592235
CDK2 1017 CHEMBL182260 CHEMBL182260 DrugBank 10592235
CDK2 1017 BOSUTINIB CHEMBL288441 inhibitor DrugBank 19039322
CDK2 1017 CHEMBL122264 CHEMBL122264 DrugBank 10592235
CDK2 1017 CHEMBL82767 CHEMBL82767 DrugBank 10592235
CDK2 1017 CHEMBL425181 CHEMBL425181 DrugBank 10592235
CDK2 1017 CHEMBL356700 CHEMBL356700 DrugBank 10592235
CDK2 1017 CHEMBL380331 CHEMBL380331 DrugBank 10592235
CDK2 1017 CHEMBL203407 CHEMBL203407 DrugBank 10592235
CDK2 1017 CHEMBL477786 CHEMBL477786 DrugBank 10592235
CDK2 1017 CHEMBL1234086 CHEMBL1234086 DrugBank 10592235
CDK2 1017 CHEMBL121941 CHEMBL121941 DrugBank 10592235
CDK2 1017 CHEMBL1234593 CHEMBL1234593 DrugBank 10592235
CDK2 1017 CHEMBL123368 CHEMBL123368 DrugBank 10592235
CDK2 1017 VARIOLIN B CHEMBL380500 DrugBank 10592235
CDK2 1017 CHEMBL424278 CHEMBL424278 NCI 8012959
CDK2 1017 APREMILAST CHEMBL514800 inhibitor TTD
CDK2 1017 Roniciclib CHEMBL3544942 inhibitor GuideToPharmacologyInteractions, ChemblInteractions, CancerCommons
CDK2 1017 PHA-793887 CHEMBL1230607 inhibitor ChemblInteractions
CDK2 1017 TG-02 CHEMBL1944698 inhibitor GuideToPharmacologyInteractions, ChemblInteractions
CDK2 1017 ALVOCIDIB CHEMBL428690 inhibitor DrugBank, GuideToPharmacologyInteractions, TdgClinicalTrial, MyCancerGenome, TTD, ChemblInteractions 11752352, 18465538
CDK2 1017 RGB-286638 CHEMBL3545083 inhibitor GuideToPharmacologyInteractions, ChemblInteractions
CDK2 1017 OLOMOUCINE CHEMBL280074 inhibitor DrugBank 11752352, 17139284, 17016423, 10592235
CDK2 1017 CHEMBL298445 CHEMBL298445 DrugBank 17139284, 17016423, 10592235
CDK2 1017 CHEMBL271591 CHEMBL271591 DrugBank 17139284, 17016423
CDK2 1017 TERFENADINE CHEMBL17157 DrugBank 17139284, 17016423, 10592235
CDK2 1017 CHEMBL272690 CHEMBL272690 DrugBank 17139284, 17016423, 10592235
CDK2 1017 CHEMBL189607 CHEMBL189607 DrugBank 17139284, 17016423, 10592235
CDK2 1017 CHEMBL47527 CHEMBL47527 DrugBank 17139284, 17016423, 10592235
CDK2 1017 CHEMBL215803 CHEMBL215803 DrugBank 10592235
CDK2 1017 CHEMBL525194 CHEMBL525194 DrugBank 10592235
CDK2 1017 CHEMBL232148 CHEMBL232148 DrugBank 10592235
CDK2 1017 CHEMBL325023 CHEMBL325023 DrugBank 10592235
CDK2 1017 CHEMBL206109 CHEMBL206109 DrugBank 10592235
CDK2 1017 CHEMBL203569 CHEMBL203569 DrugBank 10592235
CDK2 1017 CHEMBL460102 CHEMBL460102 DrugBank 10592235
CDK2 1017 CHEMBL1234085 CHEMBL1234085 DrugBank 10592235
CDK2 1017 CHEMBL455946 CHEMBL455946 DrugBank 10592235
CDK2 1017 CHEMBL445420 CHEMBL445420 DrugBank 10592235
CDK2 1017 CHEMBL518383 CHEMBL518383 DrugBank 10592235
CDK2 1017 CHEMBL509730 CHEMBL509730 DrugBank 10592235
CDK2 1017 CHEMBL1187319 CHEMBL1187319 DrugBank 10592235
CDK2 1017 MERIOLIN 3 CHEMBL270686 DrugBank 10592235
CDK2 1017 CHEMBL1235529 CHEMBL1235529 DrugBank 10592235
CDK2 1017 CHEMBL518800 CHEMBL518800 DrugBank 10592235
CDK2 1017 CHEMBL403350 CHEMBL403350 DrugBank 10592235
CDK2 1017 CHEMBL249530 CHEMBL249530 DrugBank 10592235
CDK2 1017 ACETAMINOPHEN CHEMBL112 NCI 14644624
CDK2 1017 HYDROGEN PEROXIDE CHEMBL71595 NCI 12729926
CDK2 1017 INDOLE-3-CARBINOL CHEMBL155625 NCI 15611077
CDK2 1017 PACLITAXEL CHEMBL428647 NCI 16020661
CDK2 1017 DAUNORUBICIN CHEMBL178 NCI 11368357
CDK2 1017 AG-24322 CHEMBL3545420 inhibitor ChemblInteractions, TTD
CDK2 1017 AT-7519 CHEMBL445813 inhibitor TdgClinicalTrial, GuideToPharmacologyInteractions, ChemblInteractions, DrugBank, TTD 10592235
CDK2 1017 ALOISINE CHEMBL306498 inhibitor GuideToPharmacologyInteractions
CDK2 1017 BOHEMINE CHEMBL83980 inhibitor GuideToPharmacologyInteractions
CDK2 1017 BX-795 CHEMBL577784 inhibitor GuideToPharmacologyInteractions
CDK2 1017 CHEMBL80713 CHEMBL80713 inhibitor GuideToPharmacologyInteractions
CDK2 1017 SCH-900776 CHEMBL2386889 inhibitor GuideToPharmacologyInteractions
CDK2 1017 CHEMBL361348 CHEMBL361348 DrugBank 17139284, 17016423
CDK2 1017 CHEMBL73303 CHEMBL73303 DrugBank 17139284, 17016423, 10592235
CDK2 1017 CHEMBL324942 CHEMBL324942 DrugBank 17139284, 17016423, 10592235
CDK2 1017 CHEMBL1231801 CHEMBL1231801 DrugBank 17139284, 17016423, 10592235
CDK2 1017 CHEMBL232557 CHEMBL232557 DrugBank 10592235
CDK2 1017 CHEMBL249334 CHEMBL249334 DrugBank 10592235
CDK2 1017 CHEMBL341273 CHEMBL341273 DrugBank 10592235
CDK2 1017 CHEMBL401377 CHEMBL401377 DrugBank 10592235
CDK2 1017 CHEMBL555205 CHEMBL555205 DrugBank 10592235
CDK2 1017 GSK-237701A CHEMBL222419 DrugBank 10592235
CDK2 1017 CHEMBL173682 CHEMBL173682 DrugBank 10592235
CDK2 1017 CHEMBL233553 CHEMBL233553 DrugBank 10592235
CDK2 1017 CHEMBL233149 CHEMBL233149 DrugBank 10592235
CDK2 1017 CHEMBL233970 CHEMBL233970 DrugBank 10592235
CDK2 1017 CHEMBL233349 CHEMBL233349 DrugBank 10592235
CDK2 1017 CHEMBL215205 CHEMBL215205 DrugBank 10592235
CDK2 1017 CHEMBL522891 CHEMBL522891 DrugBank 10592235
CDK2 1017 RG-547 CHEMBL384304 inhibitor ChemblInteractions, DrugBank, TTD 10592235
CDK2 1017 CHEMBL1234088 CHEMBL1234088 DrugBank 10592235
CDK2 1017 CHEMBL456163 CHEMBL456163 DrugBank 10592235
CDK2 1017 CHEMBL458926 CHEMBL458926 DrugBank 10592235
CDK2 1017 MERIOLIN 5 CHEMBL270687 DrugBank 10592235
CDK2 1017 CHEMBL360520 CHEMBL360520 DrugBank 10592235
CDK2 1017 CHEMBL249736 CHEMBL249736 DrugBank 10592235
CDK2 1017 CHEMBL476189 CHEMBL476189 DrugBank 10592235
CDK2 1017 BRYOSTATIN CHEMBL449158 NCI 14980523
CDK2 1017 RESVERATROL CHEMBL165 NCI 15122319
CDK2 1017 LOVASTATIN CHEMBL503 NCI 9553123
CDK2 1017 STANOLONE CHEMBL27769 NCI 10698512
CDK2 1017 ERIBULIN CHEMBL1683590 CIViC 26006067
CDK2 1017 CARBOPLATIN CHEMBL1351 CIViC 26006067
CDK2 1017 BETA-LAPACHONE CHEMBL15192 NCI 12689523

Variant-drug associations (data source: PharmGKB)
Gene Name Variant Alleles Chemical Phenotype Category Significance Notes Sentence Publications Annotation ID